JP2011522561A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011522561A5 JP2011522561A5 JP2011513436A JP2011513436A JP2011522561A5 JP 2011522561 A5 JP2011522561 A5 JP 2011522561A5 JP 2011513436 A JP2011513436 A JP 2011513436A JP 2011513436 A JP2011513436 A JP 2011513436A JP 2011522561 A5 JP2011522561 A5 JP 2011522561A5
- Authority
- JP
- Japan
- Prior art keywords
- synthetic peptide
- recombinant phage
- peptide according
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 26
- 241000712461 unidentified influenza virus Species 0.000 claims description 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 11
- 230000004927 fusion Effects 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- 102000012750 Membrane Glycoproteins Human genes 0.000 claims description 3
- 108010090054 Membrane Glycoproteins Proteins 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 208000002979 Influenza in Birds Diseases 0.000 claims 2
- 206010064097 avian influenza Diseases 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 210000002845 virion Anatomy 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 101710132601 Capsid protein Proteins 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000017610 release of virus from host Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 230000007502 viral entry Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20082061 | 2008-06-12 | ||
| MYPI20082061A MY160435A (en) | 2008-06-12 | 2008-06-12 | A novel antiviral peptide against avian influenza virus h9n2 |
| PCT/MY2009/000071 WO2009151313A1 (en) | 2008-06-12 | 2009-06-10 | A novel antiviral peptide against avian influenza virus h9n2 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011522561A JP2011522561A (ja) | 2011-08-04 |
| JP2011522561A5 true JP2011522561A5 (cg-RX-API-DMAC7.html) | 2012-07-19 |
| JP5647111B2 JP5647111B2 (ja) | 2014-12-24 |
Family
ID=41416902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513436A Expired - Fee Related JP5647111B2 (ja) | 2008-06-12 | 2009-06-10 | トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8883480B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2300492B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5647111B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2300492T3 (cg-RX-API-DMAC7.html) |
| MY (1) | MY160435A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009151313A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2807043A1 (en) * | 2010-08-03 | 2012-02-09 | University Of Washington Through Its Center For Commercialization | Polypeptides for treating and/or limiting influenza infection |
| CN102830225B (zh) * | 2012-09-24 | 2014-06-04 | 中国动物疫病预防控制中心 | 一种源于禽流感病毒自然弱毒株的血凝素和免疫抗原 |
| MY184269A (en) * | 2015-11-27 | 2021-03-30 | Viramatix Sdn Bhd | Broad-spectrum anti-influenza virus therapeutic peptides |
| MX2019013874A (es) | 2017-05-26 | 2020-07-28 | Viramatix Sdn Bhd | Peptidos y sus usos como agentes antivirales. |
| EP3837275A4 (en) | 2018-06-29 | 2022-07-13 | Fred Hutchinson Cancer Center | BAR CODED DEEP MUTATION SCAN LIBRARIES STORED IN A CELL, AND USES OF SUCH LIBRARIES |
| CN109487012B (zh) * | 2019-01-07 | 2020-09-22 | 广西壮族自治区兽医研究所 | 用于检测9个na亚型aiv的引物组合及其应用 |
| CN109487011B (zh) * | 2019-01-07 | 2022-03-01 | 广西壮族自治区兽医研究所 | 用于检测h5、h7和h9以及9个na亚型aiv的引物组合及其应用 |
| CN109628641B (zh) * | 2019-01-07 | 2022-03-01 | 广西壮族自治区兽医研究所 | 用于检测h7以及5个na亚型aiv的引物组合及其应用 |
| US11821111B2 (en) | 2019-11-15 | 2023-11-21 | Fred Hutchinson Cancer Center | Barcoded influenza viruses and deep mutational scanning libraries including the same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| WO1999047656A2 (en) * | 1998-03-17 | 1999-09-23 | Gendaq Limited | Nucleic acid binding proteins |
| WO2000059932A1 (fr) * | 1999-03-31 | 2000-10-12 | Otsuka Pharmaceutical Co., Ltd. | Peptides se liant a l'hemagglutinine du virus de la grippe |
| IL159797A0 (en) * | 2001-07-11 | 2004-06-20 | Palatin Technologies Inc | Linear and cyclic melanocortin receptor-specific peptides |
| US7888121B2 (en) * | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US20070042001A1 (en) * | 2005-08-16 | 2007-02-22 | Hawaii Biotech, Inc. | Influenza recombinant subunit vaccine |
| US8299214B2 (en) * | 2006-03-13 | 2012-10-30 | Keio University | Influenza infection-inhibiting peptide, influenza virus infection inhibitor, liposome, and influenza preventive/therapeutic agent |
| CA2667974A1 (en) * | 2006-07-05 | 2008-01-10 | The Scripps Research Institute | Chimeric zinc finger recombinases optimized for catalysis by directed evolution |
| US8778847B2 (en) * | 2007-06-13 | 2014-07-15 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Immunogenic peptides of influenza virus |
| CN103254308B (zh) * | 2007-06-15 | 2015-01-21 | 厦门大学 | H5亚型禽流感病毒血凝素蛋白的单克隆抗体或其结合活性片段及其用途 |
-
2008
- 2008-06-12 MY MYPI20082061A patent/MY160435A/en unknown
-
2009
- 2009-06-10 WO PCT/MY2009/000071 patent/WO2009151313A1/en not_active Ceased
- 2009-06-10 DK DK09762696.4T patent/DK2300492T3/da active
- 2009-06-10 US US12/995,889 patent/US8883480B2/en not_active Expired - Fee Related
- 2009-06-10 JP JP2011513436A patent/JP5647111B2/ja not_active Expired - Fee Related
- 2009-06-10 EP EP09762696.4A patent/EP2300492B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011522561A5 (cg-RX-API-DMAC7.html) | ||
| JP5647111B2 (ja) | トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド | |
| JP2015212284A5 (cg-RX-API-DMAC7.html) | ||
| CN114478758B (zh) | 靶向SARS-CoV-2的纳米抗体及制备方法和应用 | |
| CN104774249A (zh) | 猪流行性腹泻病毒m蛋白亲和肽及其筛选方法 | |
| Ramanujam et al. | Novel peptides that inhibit the propagation of Newcastle disease virus | |
| US9750799B2 (en) | Broad spectrum influenza A neutralizing vaccines and D-peptidic compounds, and methods for making and using the same | |
| CN105646717B (zh) | 一种长效hiv融合抑制剂及其应用 | |
| CN104650185B (zh) | 一条与猪瘟e0蛋白相结合的多肽序列及其应用 | |
| CN104744572B (zh) | 禽和猪戊型肝炎病毒共有抗原、单克隆抗体和制备方法及应用 | |
| CN102584952B (zh) | 一种丙型肝炎病毒f蛋白的抗原构象表位模拟肽及其应用 | |
| JP2019509040A (ja) | ポリペプチドライブラリ | |
| CN106478777B (zh) | 具有免疫保护性的金黄色葡萄球菌FnBPA‑A蛋白模拟表位肽、模拟表位肽组合物及其应用 | |
| CN101186644A (zh) | H3型流感病毒血凝素空间构象模拟抗原表位及其应用 | |
| CN104277113B (zh) | 抑制hiv感染的二价多肽 | |
| CN119569836B (zh) | Rsv f蛋白突变体及其应用 | |
| JP2012522021A (ja) | 合成ペプチド及びその応用 | |
| CN105085621B (zh) | 一条与乙脑病毒e蛋白相结合的多肽及其应用 | |
| WO1997045743A1 (en) | A method for selecting target pathogen inhibiting substances and test kits for use therein | |
| US20060275309A1 (en) | Peptide oligomers for use as hiv vaccines | |
| US20180280520A1 (en) | Compositions and methods related to inhibition of respiratory syncytial virus entry | |
| CN101213212A (zh) | 削弱hiv-1增殖的方法和组合物 | |
| CN106749646B (zh) | 单克隆抗体3d9识别的口蹄疫病毒血清型共享性表位及其应用 | |
| KR100498912B1 (ko) | 인간의 면역결핍 바이러스의 ｐｓｉ ＲＮＡ 염기서열에특이적으로 결합하는 펩티드 | |
| CN100445296C (zh) | 多肽有机化合物及其在异种移植中的应用 |